Andres Redondo (A Redondo, Andrés Redondo)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Venues

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

International journal of molecular sciences

Journal of ovarian research

Universidad Autónoma de Madrid

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad Autónoma de Madrid

Spain

Researcher :: Medicina

Publications

David S Moura, Jesus M Lopez-Marti, Iva Benesova, Carlos E De Andrea, Davide Di Lernia, Serena Lacerenza, Jose L Mondaza-Hernandez, Marta Martín-Ruiz, Marta Ramirez-Calvo, Giovanni Grignani, Javier Martínez Trufero, Andres Redondo, Claudia María Valverde, Silvia Stacchiotti, Antonio L Pousa, Jose Antonio Lopez-Guerrero, Antonio Gutierrez, Victor Encinas, Nadia Hindi, Dario Sangiolo, Jose Antonio Lopez-Martin, Zuzana Ozaniak Strizova, Javier Martín-Broto
Predictive and dynamic signature for anti-angiogenics in combination with PD-1 inhibitor in soft-tissue sarcoma: correlative studies linked to the IMMUNOSARC trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Rosa Álvarez Álvarez, Aránzazu Manzano, Carolina Agra Pujol, Vicente Artigas Raventós, Raquel Correa, Josefina Cruz Jurado, Juan Angel Fernandez, Xavier Garcia Del Muro, Jose Antonio Gonzalez, Nadia Hindi, Pablo Lozano Lominchar, Javier Martínez Trufero, Ramiro J Méndez, Mercedes Muñoz, Cristobal Muñoz Casares, Francisco Orbis Castellanos, Ruth Orellana, Miguel Paniagua González, Andres Redondo, Claudia Valverde Morales, José Manuel Asencio
Updated Review and Clinical Recommendations for the Diagnosis and Treatment of Patients with Retroperitoneal Sarcoma by the Spanish Sarcoma Research Group (GEIS). Cancers 15 (12) (2023)
Rosa Álvarez Álvarez, Aránzazu Manzano, Carolina Agra Pujol, Vicente Artigas Raventós, Raquel Correa, Josefina Cruz Jurado, Juan Angel Fernandez, Xavier Garcia Del Muro, Jose Antonio Gonzalez, Nadia Hindi, Pablo Lozano Lominchar, Javier Martínez Trufero, Ramiro J Méndez, Mercedes Muñoz, Cristobal Muñoz Casares, Francisco Orbis Castellanos, Ruth Orellana, Miguel Paniagua González, Andres Redondo, Claudia Valverde Morales, José Manuel Asencio
Updated Review and Clinical Recommendations for the Diagnosis and Treatment of Patients with Retroperitoneal Sarcoma by the Spanish Sarcoma Research Group (GEIS). Cancers 15 (12) (2023)
Marta Mendiola, Victoria Heredia-Soto, Ignacio Ruz-Caracuel, Amparo Baillo, Jorge Luis Ramon-Patino, Francisco Javier Escudero, Maria Miguel, Alberto Pelaez-García, Alicia Hernandez, Jaime Feliu, David Hardisson, Andres Redondo
Comparison of Methods for Testing Mismatch Repair Status in Endometrial Cancer. International journal of molecular sciences 24 (19) (2023)
Laura Gutierrez-Sainz, Sara Martinez-Fdez, Jorge Pedregosa-Barbas, Jesus Peña, Maria Alameda, David Viñal, Julia Villamayor, Sergio Martinez-Recio, Pablo Perez-Wert, Ana Pertejo-Fernandez, Alejandro Gallego, Virginia Martinez-Marin, Pilar Zamora, Enrique Espinosa, Marta Mendiola, Jaime Feliu, Andres Redondo
Efficacy of second and third lines of treatment in advanced soft tissue sarcomas: a real-world study. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Andres Redondo, Maria-Pilar Barretina Ginesta, José Alejandro Pérez-Fidalgo, María Jesús Rubio, Antonio Gonzáles Martin
Controversies in the treatment of advanced ovarian cancer in the PARP inhibitors era: a Delphi consensus. Journal of gynecologic oncology (2023)
David Pizarro, Ignacio Romero, Belén Pérez-Mies, Andres Redondo, Tamara Caniego-Casas, Irene Carretero-Barrio, Eva Cristóbal, Ana Gutiérrez-Pecharromán, Ana Santaballa, Emanuela D'Angelo, David Hardisson, Begoña Vieites, Xavier Matías-Guiu, Purificación Estévez, Eva Guerra, Jaime Prat, Andrés Poveda, Jose Antonio Lopez-Guerrero, José Palacios
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO). International journal of molecular sciences 24 (13) (2023)
Jorge Luis Ramon-Patino, Ignacio Ruz-Caracuel, Victoria Heredia-Soto, Luis Eduardo Garcia de la Calle, Bulat Zagidullin, Yinyin Wang, Alberto Berjon, Alvaro Lopez-Janeiro, Maria Miguel, Javier Escudero, Alejandro Gallego, Beatriz Castelo, Laura Yebenes, Alicia Hernandez, Jaime Feliú-Batlle, Alberto Pelaez-García, Jing Tang, David Hardisson, Marta Mendiola, Andres Redondo
Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy? Cancers 14 (4) (2022)
Andres Redondo, Ana Oaknin, Maria Jesus Rubio, Maria-Pilar Barretina-Ginesta, Ana de Juan, Luis Manso, Ignacio Romero, Cristina Martin-Lorente, Andres Poveda, Antonio Gonzalez-Martin
Management of advanced ovarian cancer in Spain: an expert Delphi consensus. Journal of ovarian research 14 (1) (2021)
Ignacio Ruz-Caracuel, Álvaro López-Janeiro, Victoria Heredia-Soto, Jorge Luis Ramon-Patino, Laura Yébenes, Alberto Berjon, Alicia Hernández Gutiérrez, Alejandro Gallego, Patricia Ruiz, Andres Redondo, Alberto Pelaez-García, Marta Mendiola, David Hardisson
Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma. Virchows Archiv : an international journal of pathology (2021)
Andres Redondo, E Guerra, L Manso, C Martin-Lorente, J Martinez-Garcia, J A Perez-Fidalgo, M Q Varela, M J Rubio, M P Barretina-Ginesta, A Gonzalez-Martin
SEOM clinical guideline in ovarian cancer (2020). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 23 (5) (2021)
D Viñal, D Martinez, J A Garcia-Cuesta, L Gutierrez-Sainz, S Martinez-Recio, J Villamayor, V Martinez-Marin, A Gallego, E Ortiz-Cruz, M Mendiola, J J Pozo-Kreilinger, A Berjon, B Belinchon, D Bernabeu, E Espinosa, J Feliu, Andres Redondo
Prognostic value of neutrophil-to-lymphocyte ratio and other inflammatory markers in patients with high-risk soft tissue sarcomas. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (10) (2020)
Elena García-Martínez, Andres Redondo, Josep Maria Piulats, Analía Rodríguez, Antonio Casado
Are antiangiogenics a good 'partner' for immunotherapy in ovarian cancer? Angiogenesis 23 (4) (2020)
A Gallego, J Ramon-Patino, J Brenes, M Mendiola, A Berjon, G Casado, B Castelo, E Espinosa, A Hernandez, D Hardisson, J Feliu, Andres Redondo
Bevacizumab in recurrent ovarian cancer: could it be particularly effective in patients with clear cell carcinoma? Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 23 (3) (2020)
Ignacio Ruz-Caracuel, Jorge L Ramón-Patino, Álvaro López-Janeiro, Laura Yébenes, Alberto Berjon, Alicia Hernández, Alejandro Gallego, Victoria Heredia-Soto, Marta Mendiola, Andres Redondo, Alberto Peláez-García, David Hardisson
Myoinvasive Pattern as a Prognostic Marker in Low-Grade, Early-Stage Endometrioid Endometrial Carcinoma. Cancers 11 (12) (2019)

Andres Redondo.css-eqlu8i{font-size:small;padding-left:4px;} (A Redondo, Andrés Redondo)

Publication Activity (10 Years)

Top Topics

Top Venues

Andres Redondo (A Redondo, Andrés Redondo)